G. Çalıbaşı Koçal Et Al. , "A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors," 24.Ulusal Biyokimya Kongresi , Konya, Turkey, pp.11, 2012
Çalıbaşı Koçal, G. Et Al. 2012. A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors. 24.Ulusal Biyokimya Kongresi , (Konya, Turkey), 11.
Çalıbaşı Koçal, G., Başbınar, Y., Alyürük, H., Çavaş, L., Öztop, İ., Sağol, Ö., ... Ellidokuz, H.(2012). A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors . 24.Ulusal Biyokimya Kongresi (pp.11). Konya, Turkey
Çalıbaşı Koçal, GİZEM Et Al. "A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors," 24.Ulusal Biyokimya Kongresi, Konya, Turkey, 2012
Çalıbaşı Koçal, GİZEM Ç. Et Al. "A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors." 24.Ulusal Biyokimya Kongresi , Konya, Turkey, pp.11, 2012
Çalıbaşı Koçal, G. Et Al. (2012) . "A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors." 24.Ulusal Biyokimya Kongresi , Konya, Turkey, p.11.
@conferencepaper{conferencepaper, author={GİZEM ÇALIBAŞI KOÇAL Et Al. }, title={A novel mutation (N567Y) can effect imatinib therapy response by stabilization of active KIT protein in gastrointestinal stromal tumors}, congress name={24.Ulusal Biyokimya Kongresi}, city={Konya}, country={Turkey}, year={2012}, pages={11} }